Barnett Eva Renee, Chief Financial Officer of Immunovant, Inc. ($IMVT), sold shares on the open market three times in the last 365 days for a total of $188 thousand. Her most recent sale occurred on April 16, 2025. These sales rank her 8,548th among 11,678 individual insiders by total amount sold, well below the average of $8.6 million across 6.4 transactions per insider. She made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 16, 2025 | Immunovant, Inc. | $IMVT | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 2993 | $14.89 | 396,774.0000 | 0 | 0.75% | 0.00% |
| April 9, 2025 | Immunovant, Inc. | $IMVT | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 7013 | $12.99 | 403,817.0000 | 0 | 1.71% | 0.00% |
| April 9, 2025 | Immunovant, Inc. | $IMVT | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 4050 | $12.99 | 399,767.0000 | 0 | 1.00% | 0.00% |
| April 1, 2025 | Immunovant, Inc. | $IMVT | Barnett Eva Renee | Chief Financial Officer | A | Common Stock | 88878 | $0.00 | 410,830.0000 | 0 | 27.61% | 0.00% |
| April 1, 2025 | Immunovant, Inc. | $IMVT | Barnett Eva Renee | Chief Financial Officer | A | Stock Option (right to buy) | 125180 | $0.00 | 125,180.0000 | 0 | 9999.99% | 0.00% |
| Feb. 19, 2025 | Immunovant, Inc. | $IMVT | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 2814 | $20.86 | 321,952.0000 | 0 | 0.87% | 0.00% |
| Jan. 15, 2025 | Immunovant, Inc. | $IMVT | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 2189 | $23.81 | 324,875.0000 | 0 | 0.67% | 0.00% |
| Jan. 15, 2025 | Immunovant, Inc. | $IMVT | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 109 | $24.19 | 324,766.0000 | 0 | 0.03% | 0.00% |
| Jan. 8, 2025 | Immunovant, Inc. | $IMVT | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 4105 | $24.10 | 327,064.0000 | 0 | 1.24% | 0.00% |
| Nov. 20, 2024 | Immunovant, Inc. | $IMVT | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 4174 | $25.45 | 331,169.0000 | 0 | 1.24% | 0.00% |
| Oct. 16, 2024 | Immunovant, Inc. | $IMVT | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 3271 | $28.79 | 335,343.0000 | 0 | 0.97% | 0.00% |
| Oct. 9, 2024 | Immunovant, Inc. | $IMVT | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 5162 | $29.56 | 338,614.0000 | 0 | 1.50% | 0.00% |
| Aug. 21, 2024 | Immunovant, Inc. | $IMVT | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 3619 | $31.84 | 343,925.0000 | 0 | 1.04% | 0.00% |
| Aug. 21, 2024 | Immunovant, Inc. | $IMVT | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 149 | $32.32 | 343,776.0000 | 0 | 0.04% | 0.00% |
| July 17, 2024 | Immunovant, Inc. | $IMVT | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 2939 | $29.64 | 347,728.0000 | 0 | 0.84% | 0.00% |
| July 17, 2024 | Immunovant, Inc. | $IMVT | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 184 | $30.55 | 347,544.0000 | 0 | 0.05% | 0.00% |
| July 9, 2024 | Immunovant, Inc. | $IMVT | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 4747 | $28.06 | 350,667.0000 | 0 | 1.34% | 0.00% |
| May 22, 2024 | Immunovant, Inc. | $IMVT | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 4042 | $29.65 | 355,414.0000 | 0 | 1.12% | 0.00% |
| April 17, 2024 | Immunovant, Inc. | $IMVT | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 9479 | $28.80 | 362,230.0000 | 0 | 2.55% | 0.00% |
| April 17, 2024 | Immunovant, Inc. | $IMVT | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 2774 | $29.94 | 359,456.0000 | 0 | 0.77% | 0.00% |
| April 9, 2024 | Immunovant, Inc. | $IMVT | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 3689 | $31.18 | 371,709.0000 | 0 | 0.98% | 0.00% |
| April 2, 2024 | Immunovant, Inc. | $IMVT | Barnett Eva Renee | Chief Financial Officer | A | Common Stock | 54978 | $0.00 | 375,398.0000 | 0 | 17.16% | 0.00% |
| April 2, 2024 | Immunovant, Inc. | $IMVT | Barnett Eva Renee | Chief Financial Officer | A | Stock Option (right to buy) | 68723 | $0.00 | 68,723.0000 | 0 | 9999.99% | 0.00% |
| Feb. 22, 2024 | Immunovant, Inc. | $IMVT | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 2930 | $36.15 | 320,420.0000 | 0 | 0.91% | 0.00% |
| Jan. 11, 2024 | Immunovant, Inc. | $IMVT | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 2681 | $41.64 | 324,184.0000 | 0 | 0.82% | 0.00% |
| Jan. 11, 2024 | Immunovant, Inc. | $IMVT | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 834 | $42.43 | 323,350.0000 | 0 | 0.26% | 0.00% |